不同的转录组特征的外周血液单核细胞在非血性慢性阻塞性肺病的非血性慢性阻塞性肺病
Takuro Imamoto1, Takeshi Kawasaki1, Hironori Sato2
1Department of Respirology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
International journal of molecular sciences
|January 11, 2024
概括
非血栓性慢性阻塞性肺病 (COPD) 涉及不同的外周血液单核细胞 (PBMC) 基因表达. 这些变化表明潜在的2型免疫反应和呼吸道重塑,表明喘的潜力.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 慢性阻塞性肺病 (COPD) 是异质的,有不同的表型,如缩性和非缩性形式.
- 胸部计算机断层扫描 (CT) 定义了非血栓性COPD,但其潜在的分子机制,特别是外围血液单核细胞 (PBMC),仍然不完全理解.
研究的目的:
- 为了研究非血性COPD中PBMCs的转录组特征.
- 鉴定这种COPD表型的PBMC中差异表达基因 (DEG) 和相关途径.
- 探索这些分子发现对疾病发病和临床表现的潜在影响.
主要方法:
- 来自非血性COPD患者的PBMCs的转录组分析.
- 基因和基因组的京都百科全书 (KEGG) 路径丰富分析.
- 差异基因表达分析以确定关键的上调基因.
主要成果:
- 与强血性COPD相比,非强血性COPD的PBMC表现出独特的转录组特征.
- "造血细胞系"的途径显著上调,涉及PBMCs在肺病理.
- 像XCL1,PRKCZ,TMEM102,CD200R1和AQP1这样的升级调节的DEGs表明T淋巴细胞和乙氨基酸细胞的激活.
- 鉴定了参与酸盐生物合成,细胞外矩阵相互作用 (ITGA3),原沉积 (COL6A1),气道壁加厚 (HSPG2,PDGFRB,PAK4) 和血管保护 (SERPINF1) 的基因.
结论:
- 在非血性COPD中,PBMC基因表达反映了2型免疫反应和呼吸道重塑.
- 这些分子特征表明潜在的喘潜力,即使没有临床喘症状.
- 这些发现在分子层面上区分了非血性COPD与血性形式.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Pathogenesis and Clinical Features
275
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
275
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K


